A detailed history of Parallel Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 124,423 shares of PFE stock, worth $3.33 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
124,423
Previous 108,180 15.01%
Holding current value
$3.33 Million
Previous $3.03 Million 18.97%
% of portfolio
0.09%
Previous 0.08%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $449,931 - $509,867
16,243 Added 15.01%
124,423 $3.6 Million
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $438,766 - $514,152
17,370 Added 19.13%
108,180 $3.03 Million
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $691,340 - $793,880
26,703 Added 41.65%
90,810 $2.52 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $359,182 - $466,539
-13,746 Reduced 17.66%
64,107 $1.85 Million
Q3 2023

May 20, 2024

SELL
$32.09 - $37.51 $447,848 - $523,489
-13,956 Reduced 15.2%
77,853 $2.58 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $447,848 - $523,489
-13,956 Reduced 15.2%
77,853 $2.58 Million
Q2 2023

May 20, 2024

BUY
$36.12 - $41.79 $194,614 - $225,164
5,388 Added 6.23%
91,809 $3.37 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $194,614 - $225,164
5,388 Added 6.23%
91,809 $3.37 Million
Q1 2023

May 20, 2024

SELL
$39.39 - $51.28 $172,882 - $225,067
-4,389 Reduced 4.83%
86,421 $3.53 Million
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $245,399 - $319,474
6,230 Added 7.77%
86,421 $3.53 Million
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $388,525 - $507,177
9,306 Added 13.13%
80,191 $4.11 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $161,518 - $197,173
-3,691 Reduced 4.95%
70,885 $3.1 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $91,291 - $108,243
1,962 Added 2.7%
74,576 $3.91 Million
Q1 2022

Apr 28, 2022

SELL
$45.75 - $56.69 $460,931 - $571,151
-10,075 Reduced 12.18%
72,614 $3.81 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $108,919 - $161,455
2,636 Added 3.29%
82,689 $4.88 Million
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $215,992 - $277,461
5,503 Added 7.38%
80,053 $3.44 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $292,343 - $331,175
8,141 Added 12.26%
74,550 $2.92 Million
Q1 2021

Apr 23, 2021

BUY
$33.49 - $37.77 $44,575 - $50,271
1,331 Added 2.05%
66,409 $2.41 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $80,629 - $102,527
-2,409 Reduced 3.57%
65,078 $2.4 Million
Q3 2020

Oct 27, 2020

BUY
$31.75 - $37.25 $54,387 - $63,809
1,713 Added 2.6%
67,487 $2.48 Million
Q2 2020

Jul 16, 2020

BUY
$30.12 - $36.54 $290,898 - $352,903
9,658 Added 17.21%
65,774 $2.15 Million
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $486 - $695
18 Added 0.03%
56,116 $1.83 Million
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $26,928 - $30,560
818 Added 1.48%
56,098 $2.2 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $160,045 - $207,532
-4,926 Reduced 8.18%
55,280 $1.99 Million
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $14,200 - $15,943
384 Added 0.64%
60,206 $2.61 Million
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $51,525 - $56,608
1,374 Added 2.35%
59,822 $2.54 Million
Q4 2018

Feb 05, 2019

BUY
$38.47 - $43.86 $86,980 - $99,167
2,261 Added 4.02%
58,448 $2.55 Million
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $39,399 - $47,788
1,143 Added 2.08%
56,187 $2.47 Million
Q2 2018

Jul 30, 2018

BUY
$32.98 - $35.16 $338,341 - $360,706
10,259 Added 22.91%
55,044 $2 Million
Q1 2018

May 08, 2018

BUY
$31.91 - $37.02 $2,137 - $2,480
67 Added 0.15%
44,785 $1.59 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $5,388 - $5,716
162 Added 0.36%
44,718 $1.62 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $1.38 Million - $1.52 Million
44,556 New
44,556 $1.57 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $1.26 Million - $1.39 Million
-40,648 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
40,648
40,648 $1.35 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.